SUPPLEMENTARY TENDER FOR THE SUPPLY OF MEDICINES FOR THE MANAGEMENT OF CANCER IN CHILDREN AND ADOLESCENTS
UNICEF
SUPPLEMENTARY TENDER FOR THE SUPPLY OF MEDICINES FOR THE MANAGEMENT OF CANCER IN CHILDREN AND ADOLESCENTS
Request for proposal
Reference:
RFP-DAN-2024-503720
Beneficiary countries:
Multiple destinations (see 'Countries' tab below)
Registration level:
Basic
Published on:
12-Jul-2024
Deadline on:
03-Feb-2025 23:59 (GMT 2.00)
Description
UNICEF and PAHO wishes to invite to submit a proposal for "Supplementary Tender for the Supply of Medicine for the Management of Cancer in Children and Adolescents"
Ilona Schioler - ischioler@unicef.org, Tel: +45 45335500
Email:
ischioler@unicef.org
First name:
Ilona
Surname:
Schioler
Telephone country code:
Denmark (+45)
Telephone number:
45335500
Telephone extension
5994
Zaineb Rashan - zrashan@unicef.org, Tel: +45 45335994
Email:
zrashan@unicef.org
First name:
Zaineb
Surname:
Rashan
Telephone country code:
Denmark (+45)
Telephone number:
45335994
Link | Description | |
---|---|---|
https://teams.microsoft.com/l/meetup-join/19%3ameeting_NmQ4OWY1ZDMtMTZiZS00OTUxLTkxZTgtNWI5NDkyNjFiMDM4%40thread.v2/0?context=%7b%22Tid%22%3a%2277410195-14e1-4fb8-904b-ab1892023667%22%2c%22Oid%22%3a%22034f461a-d8b3-41fa-998c-9b23c88d8696%22%7d | Pre-bid Webinar for Paediatric and Adolescent Cancer Medicines Supplementary Tender |
51111602
-
Cytarabine
51111606
-
Hydroxycarbamide or hydroxyurea
51111610
-
Methotrexate
51111617
-
Gemcitabine
51111625
-
Azacitidine
51111629
-
Clofarabine
51111642
-
Irinotecan
51111650
-
Pemetrexed
51111659
-
Topotecan
51111704
-
Mitomycin
51111716
-
Rituximab
51111717
-
Trastuzumab
51111728
-
Cabazitaxel
51111731
-
Bevacizumab
51111733
-
Bleomycin
51111736
-
Cetuximab
51111739
-
Etoposide
51111740
-
Daunorubicin hydrochloride
51111742
-
Eribulin
51111746
-
Ipilimumab
51111758
-
Panitumumab
51111761
-
Ranibizumab
51111765
-
Trabectedin
51111766
-
Vinblastine
51111767
-
Vincristine
51111772
-
Vinorelbine
51111778
-
Alemtuzumab
51111779
-
Carfilzomib
51111780
-
Durvalumab
51111781
-
Olaparib
51111782
-
Obinutuzumab
51111783
-
Brentuximab vedotin
51111784
-
Atezolizumab
51111785
-
Pembrolizumab
51111786
-
Pertuzumab
51111802
-
Bicalutamide
51111803
-
Estramustine
51111805
-
Goserelin
51111815
-
Triptorelin
51111820
-
Letrozole
51111824
-
Exemestane
51111828
-
Cyproterone
51111830
-
Abiraterone
51111833
-
Axitinib
51111838
-
Bortezomib
51111842
-
Degarelix
51111855
-
Lanreotide
51111856
-
Lapatinib
51111862
-
Nilotinib
51111863
-
Octreotide
51111873
-
Tamoxifen
51111874
-
Tamoxifen citrate
51111875
-
Anastrozole
51111876
-
Leuprorelin
51111877
-
Enzalutamide
51111878
-
Goserelin acetate
51111901
-
Asparaginase
51111904
-
Paclitaxel
51112001
-
Capecitabine
51112002
-
Dasatinib
51112004
-
Gefitinib
51112005
-
Imatinib
51112006
-
Pazopanib
51112008
-
Sorafenib
51112010
-
Vandetanib
51112012
-
Afatinib
51112014
-
Erlotinib hydrochloride
51112015
-
Imatinib mesiate or mesylate
51112016
-
Sorafenib tosylate
51112017
-
Sunitinib malate
51112020
-
Ceritinib
51112021
-
Palbociclib
51112022
-
Ibrutinib
51112023
-
Ruxolitinib
51112026
-
Cabozantinib
51112027
-
Regorafenib
51112028
-
Nintedanib
51112029
-
Abemaciclib
51112030
-
Ribociclib
51112031
-
Lenvatinib
51112032
-
Crizotinib
51112033
-
Baricitinib
51112034
-
Osimertinib
51112035
-
Alectinib
51112037
-
Midostaurin
51112088
-
Acalabrutinib
51112301
-
Busulfan
51112402
-
Dacarbazine
51112503
-
Bendamustine
51112505
-
Chlorambucil
51112507
-
Cyclophosphamide
51112508
-
Bendamustine hydrochloride
51112510
-
Ifosfamide
51112513
-
Melphalan
51112601
-
Carmustine
51112701
-
Carboplatin
51112702
-
Cisplatin
51112705
-
Oxaliplatin
51112804
-
Raloxifene
51112901
-
Amifostine
51112902
-
Temozolomide
51113000
-
Alkylating agent amines
51113501
-
Pipobroman
51113502
-
Piposulfan
51113503
-
Venetoclax
51201569
-
Atlizumab or tocilizumab
51201571
-
Blinatumomab
51201571
-
Blinatumomab
51201573
-
Nivolumab
51201574
-
Palivizumab
51201575
-
Ocrelizumab
51201576
-
Tofacitinib
51201580
-
Ixekizumab
51201604
-
Diphteria vaccine
51201606
-
Hemophilus influenzae vaccine
51201607
-
Hepatitis B virus vaccine
51201608
-
Influenza virus vaccine
51201609
-
Measles virus vaccine
51201610
-
Meningococcal vaccine
51201615
-
Pneumococcal vaccine
51201616
-
Poliovirus vaccine
51201617
-
Rabies vaccine
51201618
-
Rota virus vaccine
51201621
-
Tetanus vaccine
51201623
-
Typhoid vaccine
51201624
-
Varicella virus vaccine
51201625
-
Yellow fever vaccine
51201626
-
Hepatitis A virus vaccine
51201627
-
Haemophilus B vaccine
51201628
-
Measles and mumps and rubella virus vaccine
51201629
-
Diphtheria and tetanus toxoids absorbed
51201631
-
Diptheria and tetanus toxoids and acellular pertussis vaccine
51201632
-
Diptheria and tetanus and wholecell pertussis vaccine
51201633
-
Haemophilus influenzae b with diptheria and tetanus and acellular pertussis
51201634
-
Haemophilus influenzae B with diptheria and tetanus and wholecell pertussis conjugated vaccine
51201646
-
Measles and rubella virus vaccine
51201648
-
Rubella and mumps virus vaccine
51201652
-
COVID19 - Pfizer Biontech
51201653
-
COVID19 - Moderna
51201654
-
COVID19 - Sputnik V
51201655
-
COVID19 - AstraZeneca
51201656
-
COVID19 - Johnson & Johnson
51201657
-
Malaria vaccine
51201658
-
Cholera vaccine
51201659
-
COVID 19 - Unspecified
51201660
-
Ebola vaccine
51201702
-
E Coli vaccines
51201703
-
Gumboro vaccines
51201704
-
Avian infectious bronchitis vaccines
51201705
-
Newcastle virus vaccine
51201802
-
Filgrastim
51201803
-
Pegfilgrastim
51201805
-
Rho D immunoglobulins
51201806
-
Gamma IGG or immunoglobulin
51201810
-
Galsulfase
51201811
-
Thalidomide
51201812
-
Mifamurtide
51201831
-
Lipegfilgrastim
51201901
-
Glatiramer acetate
51202002
-
Hyaluronan or hyaluronate or hyaluronic acid
51202203
-
Methotrexate sodium
51202204
-
Sulfasalazine
51202206
-
Dexrazoxane
51202207
-
Dexrazoxane hydrochloride
51202306
-
Etanercept
51202401
-
Adalimumab
51202402
-
Basiliximab
51202403
-
Belimumab
51202405
-
Certolizumab
51202406
-
Certolizumab pegol
51202409
-
Infliximab
51202411
-
Natalizumab
51202412
-
Omalizumab
51202413
-
Secukinumab
51202414
-
Ustekinumab
51202416
-
Daratumumab
51202417
-
Golimumab
51202501
-
Leflunomide
51202603
-
Everolimus
51202701
-
Anti-thymocyte globulin
51202801
-
Pimecrolimus
51202803
-
Sirolimus
51202804
-
Tacrolimus
51202805
-
Tacrolimus anhydrous
51203101
-
Ciclosporin or cyclosporine
51203201
-
Mycophenolate mofetil
51203202
-
Mycophenolate mofetil hydrochloride
51203203
-
Mycophenolate or mycophenolic acid
51203301
-
Lenalidomide
51203302
-
Fingolimod
51203303
-
Pomalidomide
51203401
-
Azathioprine
51203402
-
Cladribine
51203403
-
Mercaptopurine
51203605
-
Teriflunomide
51203801
-
Abatacept
51204001
-
Pirfenidone
51204201
-
Veterinary foot and mouth disease (FMD) vaccines
51204202
-
Veterinary anthrax vaccines
51204203
-
Veterinary brucella vaccines
51204204
-
Contagious bovine pleuropneumonia CBPP vaccines
51204205
-
Ovine rinderpest or peste des petit ruminants vaccines
51421501
-
Fluticasone
51421504
-
Fluticasone furoate
51421505
-
Fluticasone propionate
51421802
-
Budesonide
51422101
-
Prednisone
51422122
-
Mometasone furoate monohydrate
51422202
-
Fluorometholone
51422205
-
Flunarizine
51422206
-
Fluocinolone acetonide
51422302
-
Beclometasone or Beclomethasone
51422303
-
Betamethasone
51422306
-
Dexamethasone
51422315
-
Prednisolone
51422327
-
Betamethasone dipropionate
51422331
-
Betamethasone valerate
51422340
-
Dexamethasone phosphate
51422342
-
Dexamethasone sodium phosphate
51422354
-
Methylprednisolone acetate
51422356
-
Methylprednisolone sodium succinate
51422364
-
Prednisolone sodium phosphate
51422408
-
Deflazacort
51422415
-
Hydrocortisone
51422417
-
Hydrocortisone butyrate
51422421
-
Fludrocortisone acetate
51422425
-
Hydrocortisone acetate
51422434
-
Hydrocortisone sodium succinate
Upload of Clarifications from the Pre-bid Webinar
Edited on:
15-Aug-2024 11:40
Edited by:
mplesner@unicef.org
WINDOW 1 Proposal submission deadline extended to 13th August 2024.
Edited on:
02-Aug-2024 11:17
Edited by:
ischioler@unicef.org
Pre-bid webinar, taking place on 7th of August 2024, information is available under Documents.
Edited on:
02-Aug-2024 11:14
Edited by:
ischioler@unicef.org